Last Updated: 20/03/2026

Target Malaria

Objectives

Development of a new tool for vector control for malaria in Africa.

Principal Institution

Imperial College London, United Kingdom

Principal Investigators / Focal Persons

Austin Burt

Partner Institutions

Research Institute of Health Sciences (IRSS), Burkina Faso
Uganda Virus Research Institute (UVRI)
University of Oxford, United Kingdom
CDC Foundation, United States
Polo Genomics Genetics and Biology (Polo GGB), Italy
University of Ghana (UG)
University of Notre Dame, United States

Sub Projects

Gene Drive: Target Malaria Program
Gene drives for Malaria control
Target Malaria – Phase II 
Target Malaria Ac(PMB) trial support

Study Design

Phased development approach.

Project Outputs

Target Malaria Website

SHARE

Related Resources

Tests for glucose-6-phosphate dehydrogenase activity: Target product profiles
Guidance & Strategy
Report of an expert consultation on the clinical development plan for a multistage malaria vaccine targeting the circumsporozoite (CS) and blood stage (BS) antigens
Report
Vector control products targeting outdoor malaria transmission
Report

Related Projects

Jan 2024 —
Dec 2028

$205,000

Development of novel antimalarial therapeutics targeting Plasmodium falciparum lipid-binding proteins
Ahmadu Bello University (ABU), Nigeria
Sep 2024 —
Sep 2028
AI & data driven development of chemical probes for high value Plasmodium targets
University of Dundee, United Kingdom
Jan 2023 —
Dec 2025

$392,412

Development of novel malaria pre-erythrocytic vaccine antigens targeting Plasmodium sporozoite liver infection
Mercer University, United States
SHARE